Clinical trial
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
NCT00605410
Study timeline
Study start (unknown)2008-01-01Date precision: month
Registry last updated2009-01-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
ipratropium bromideDRUG · verified · RxNorm: ipratropium bromide
placeboDRUG
Sponsors & collaborators
University of Saskatchewanlead sponsor
Royal University Hospital Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00605410 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.